Search This Blog

Wednesday, January 10, 2007


The way to successfully complete a research project for the drug industry is to tell the leaders what they want to hear. It's rare that you'll get caught practicing a cargo cult science. This story is an acception:

WASHINGTON, Jan 10 (Reuters) - The U.S. Food and Drug Administration on Wednesday urged a number of pharmaceutical companies to confirm or repeat some studies done for them by a unit of MDS Inc. (MDS.TO: Quote, Profile , Research) (MDZ.N: Quote, Profile , Research) from 2000 to 2004.

FDA said inspections of MDS Pharma Services had raised questions about the validity and accuracy of studies that measure the level of a drug in a patient's blood and could have been used as part of the basis for FDA approval.

Shouldn't the FDA conduct these types of audits before they approve a drug? Shouldn't they insist that the studies be repeated?

No comments: